A 10 day pilot study of TTP 399 in patients with type 2 diabetes mellitus

Trial Profile

A 10 day pilot study of TTP 399 in patients with type 2 diabetes mellitus

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Jun 2016

At a glance

  • Drugs TTP 399 (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 22 Jun 2016 New trial record
    • 14 Jun 2016 Results were presented at the American Diabetes Association 76th Scientific Sessions 2016, according to a vTv Therapeutics LLC media release.
    • 14 Jun 2016 Results published in a vTv Therapeutics LLC media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top